Exhaled breath hydrogen cyanide as a marker of early Pseudomonas aeruginosa infection in children with cystic fibrosis

Hydrogen cyanide is readily detected in the headspace above Pseudomonas aeruginosa cultures and in the breath of cystic fibrosis (CF) patients with chronic (P. aeruginosa) infection. We investigated if exhaled breath HCN is an early marker of P. aeruginosa infection. 233 children with CF who were free from P. aeruginosa infection were followed for 2 years. Their median (interquartile range) age was 8.0 (5.0–12.2) years. At each study visit, an exhaled breath sample was collected for hydrogen cyanide analysis. In total, 2055 breath samples were analysed. At the end of the study, the hydrogen cyanide concentrations were compared to the results of routine microbiology surveillance. P. aeruginosa was isolated from 71 children during the study with an incidence (95% CI) of 0.19 (0.15–0.23) cases per patient-year. Using a random-effects logistic model, the estimated odds ratio (95% CI) was 3.1 (2.6–3.6), which showed that for a 1- ppbv increase in exhaled breath hydrogen cyanide, we expected a 212% increase in the odds of P. aeruginosa infection. The sensitivity and specificity were estimated at 33% and 99%, respectively. Exhaled breath hydrogen cyanide is a specific biomarker of new P. aeruginosa infection in children with CF. Its low sensitivity means that at present, hydrogen cyanide cannot be used as a screening test for this infection. Exhaled hydrogen cyanide is a specific but insensitive biomarker of new P. aeruginosa infection in children with CF http://ow.ly/TdRaF

[1]  A. Smyth,et al.  Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. , 2017, The Cochrane database of systematic reviews.

[2]  David Smith,et al.  Is Hydrogen Cyanide a Marker of Burkholderia cepacia Complex? , 2013, Journal of Clinical Microbiology.

[3]  David Smith,et al.  Hydrogen cyanide concentrations in the breath of adult cystic fibrosis patients with and without Pseudomonas aeruginosa infection , 2013, Journal of breath research.

[4]  Theo Stijnen,et al.  Methods for calculating sensitivity and specificity of clustered data: a tutorial. , 2012, Radiology.

[5]  David Smith,et al.  Quantification of hydrogen cyanide and 2-aminoacetophenone in the headspace of Pseudomonas aeruginos , 2012 .

[6]  David Smith,et al.  An investigation of suitable bag materials for the collection and storage of breath samples containing hydrogen cyanide , 2012, Journal of breath research.

[7]  Lu Meng-Sha,et al.  Determination of 17 Organo-Sulphur Compounds in Headspace of Hydrolysates of Garlic Pulpy by Selected Ion Flow Tube-Mass Spectrometry , 2012 .

[8]  L. Halonen,et al.  Background levels and diurnal variations of hydrogen cyanide in breath and emitted from skin , 2011, Journal of breath research.

[9]  David Smith,et al.  Progress in SIFT-MS: breath analysis and other applications. , 2011, Mass spectrometry reviews.

[10]  K. Webb,et al.  Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa , 2011, European Respiratory Journal.

[11]  Y. Yau,et al.  Sputum induction in routine clinical care of children with cystic fibrosis. , 2010, The Journal of pediatrics.

[12]  T.W.R. Lee.  Eradication of early Pseudomonas infection in cystic fibrosis , 2009, Chronic respiratory disease.

[13]  David Smith,et al.  Hydrogen cyanide as a biomarker for Pseudomonas aeruginosa in the breath of children with cystic fibrosis , 2009, Pediatric pulmonology.

[14]  P. Sly,et al.  Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis , 2008, European Respiratory Journal.

[15]  Tianshu Wang,et al.  Analysis of breath, exhaled via the mouth and nose, and the air in the oral cavity , 2008, Journal of breath research.

[16]  P. Sly,et al.  Disease surveillance using bronchoalveolar lavage. , 2008, Paediatric respiratory reviews.

[17]  B. Ryall,et al.  Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa. , 2007, Advances in microbial physiology.

[18]  David Smith,et al.  A general method for the calculation of absolute trace gas concentrations in air and breath from selected ion flow tube mass spectrometry data , 2006 .

[19]  A. Smyth,et al.  Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis. , 2006, The Cochrane database of systematic reviews.

[20]  P. Španěl,et al.  SELECTED ION FLOW TUBE MASS SPECTROMETRY, SIFT-MS, FOR ON-LINE TRACE GAS ANALYSIS OF BREATH , 2005 .

[21]  David Smith,et al.  Detection of volatile compounds emitted by Pseudomonas aeruginosa using selected ion flow tube mass spectrometry , 2005, Pediatric pulmonology.

[22]  Tianshu Wang,et al.  Quantification of hydrogen cyanide in humid air by selected ion flow tube mass spectrometry. , 2004, Rapid communications in mass spectrometry : RCM.

[23]  M. Denton,et al.  Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. , 2003, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[24]  J. Emerson,et al.  Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis , 2002, Pediatric pulmonology.

[25]  J. Carlin,et al.  Clinical outcome after early Pseudomonas aeruginosa infection in cystic fibrosis. , 2001, The Journal of pediatrics.

[26]  A. Morice,et al.  Sputum induction in young cystic fibrosis patients. , 2001, The European respiratory journal.

[27]  P. Spanĕl,et al.  Quantification of hydrogen sulphide in humid air by selected ion flow tube mass spectrometry. , 2000, Rapid communications in mass spectrometry : RCM.

[28]  K. De Boeck,et al.  Sputum induction in young cystic fibrosis patients. , 2000, The European respiratory journal.

[29]  A. Husain,et al.  Infection in a cystic fibrosis patient. , 2009, Archives of pathology & laboratory medicine.

[30]  J. Emerson,et al.  Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis , 1999, Pediatric pulmonology.

[31]  J. Carlin,et al.  Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis , 1996, Pediatric pulmonology.

[32]  N. Høiby,et al.  Prevention of chronic Pseudomonas aeruginosa colonisation in cystic fibrosis by early treatment , 1991, The Lancet.

[33]  Chunfang ZHANGt.  Pseudomonas aeruginosa. , 1966, Lancet.

[34]  J. Gustafson,et al.  Cystic Fibrosis , 2009, Journal of the Iowa Medical Society.

[35]  E. Goodwin.  For Children with Cystic Fibrosis , 1963 .

[36]  C. Young,et al.  PRELIMINARY REPORT ON THE PRODUCTION OF HYDROCYANIC ACID BY BACTERIA , 1913 .